Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Clearmind Medicine Inc CMND

Healthcare Psychedelics
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CMND)

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

GlobeNewswire 7 days ago

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

GlobeNewswire 7 days ago

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

GlobeNewswire February 4, 2025

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

GlobeNewswire February 4, 2025

Clearmind Medicine Announces Shareholders Meeting Results

GlobeNewswire January 7, 2025

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

GlobeNewswire January 6, 2025

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

GlobeNewswire January 6, 2025

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

GlobeNewswire January 2, 2025

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

GlobeNewswire December 26, 2024
View More News ››

Opinion & Analysis (NDAQ:CMND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CMND)

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet fo

Just In: $CMND Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol...
whytestocks - December 16, 2024

BUY BUY BUY BUY BUY

This is gona go up tomorow  
Nibinator - August 21, 2024

Clearmind Medicine Granted U.S. Patent Approval for Binge Be

Breaking News: $CMND Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior TreatmentVancouver, Canada, Aug. 21, 2024 (GLOBE...
whytestocks - August 21, 2024

Clearmind Medicine and Yissum Expand Collaboration with Inte

Just In: $CMND Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic...
whytestocks - August 16, 2024

CMND....Who u trying to kid? Good NR but......

Go ahead.....I dare ya ; ) $50 million shelf offering just filed EFFECTIVE sec.gov/Archives/edgar/data/1892500/000121390023098210...
Iseneschal - June 20, 2024

Clearmind Medicine receives Patent Approval in China for tre

NEWS: $CMND Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours--News Direct-- Clearmind Medicine Inc...
whytestocks - February 26, 2024
View more Bullboard ››

Leading Edge Materials Corp.

Leading Edge Materials Corp.

Leading Edge Materials is a Canadian public company focused on developing a portfolio of critical raw material projects ...
View More »